SEC Info
uses JavaScript!
To view pages properly, enable JavaScript in your browser.
SEC Info
℠
Home
Search
My Interests
Help
Sign In
Please
Sign In
Kintara Therapeutics, Inc.
CA
SEC # 1498382
1 Related Registrant:
TuHURA Biosciences, Inc. — 4/25/24 — SEC # 1252142
Click to view...
Registrant
About
Filings
Files
Relationships
Names
Topics
Web
169 Topics
within the
Past Year
Past Two Years
Past Three Years
Past Four Years
Past Five Years
Entire Database
Show:
Most-Recent Document
All Documents
And:
Exhibits
As Of
Filing
Doc.
Page
Title
Docs.
10/27/23
S-1/A
1
About This Prospectus
4
9/19/23
424B5
1
About This Prospectus Supplement
1
1
Additional Information
1
9/18/23
10-K
1
Business
1
10/27/23
S-1/A
1
Capitalization
3
1
Cautionary Note Regarding Forward Looking Statements
3
9/19/23
424B5
1
Cautionary Note Regarding Forward-Looking Statements
1
9/18/23
10-K
1
Certain Relationships and Related Transactions, and Director Independence
1
1
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
1
2/14/24
10-Q
1
Controls and Procedures
4
1
Defaults Upon Senior Securities
3
9/19/23
424B5
1
Description of Capital Stock
1
1
Description of Debt Securities
1
1
Description of Stock Warrants
1
1
Description of Subscription Rights
1
10/27/23
S-1/A
1
Description of the Capital Stock
3
1
Description of the Securities We Are Offering
3
9/19/23
424B5
1
Description of Units
1
10/27/23
S-1/A
1
Dilution
4
9/18/23
10-K
1
Directors, Executive Officers, and Corporate Governance
1
9/19/23
424B5
1
Disclosure of Commission Position on Indemnification for Securities Act Liabilities
1
9/18/23
10-K
1
Disclosure Regarding Foreign Jurisdictions Preventing Inspections
1
1
Executive Compensation
1
2/14/24
10-Q
1
Exhibits
4
10/27/23
S-1/A
1
Experts
4
2/14/24
10-Q
1
Financial Information
3
1
Financial Statements
3
9/18/23
10-K
1
Financial Statements and Supplementary Data
1
1
Form 10-K Summary
1
9/19/23
424B5
1
Forms of Securities
1
1
Forward-Looking Statements
1
10/27/23
S-1/A
1
Incorporation of Certain Information by Reference
4
9/18/23
10-K
1
Item 1
1
1
Item 10
1
1
Item 11
1
1
Item 12
1
1
Item 13
1
1
Item 14
1
1
Item 15
1
1
Item 16
1
1
Item 1A
1
1
Item 1B
1
1
Item 2
1
1
Item 3
1
1
Item 4
1
1
Item 5
1
1
Item 6
1
1
Item 7
1
1
Item 7A
1
1
Item 8
1
1
Item 9
1
1
Item 9A
1
1
Item 9B
1
1
Item 9C
1
10/27/23
S-1/A
1
Legal Matters
4
2/14/24
10-Q
1
Legal Proceedings
4
1
Management's Discussion and Analysis of Financial Condition and Results of Operations
4
9/18/23
10-K
1
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
1
10/27/23
S-1/A
1
Market Price of Our Common Stock
4
2/14/24
10-Q
1
Mine Safety Disclosures
4
10/27/23
S-1/A
1
Offering, The
4
2/14/24
10-Q
1
Other Information
4
9/18/23
10-K
1
Part I
1
2/14/24
10-Q
1
Part I. -- Financial Information
3
9/18/23
10-K
1
Part Ii
1
2/14/24
10-Q
1
Part Ii -- Other Information
3
9/18/23
10-K
1
Part Iii
1
1
Part Iv
1
10/27/23
S-1/A
1
Plan of Distribution
4
9/18/23
10-K
1
Principal Accountant Fees and Services
1
1
Properties
1
10/27/23
S-1/A
1
Prospectus Summary
4
9/19/23
424B5
1
Prospectus Supplement Summary
1
2/14/24
10-Q
1
Quantitative and Qualitative Disclosures About Market Risk
4
9/18/23
10-K
1
Reserved
1
2/14/24
10-Q
1
Risk Factors
8
9/19/23
424B5
1
Securities We May Offer, The
1
9/18/23
10-K
1
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
1
1
Signatures
1
10/27/23
S-1/A
1
The Offering
4
9/19/23
424B5
1
The Securities We May Offer
1
5/11/23
10-Q
1
Unregistered Sales of Equity Securities and Use of Proceeds
1
2/14/24
10-Q
1
Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
2
9/18/23
10-K
1
Unresolved Staff Comments
1
10/27/23
S-1/A
1
Use of Proceeds
4
1
Where You Can Find More Information
4
↑
Top
Copyright © 2024
Fran Finnegan & Company LLC
– All Rights Reserved.
About
—
Privacy
—
Redactions
—
Help
— Mon., Apr. 29, 11:48:33.
2am ET